Zobrazeno 1 - 10
of 16
pro vyhledávání: '"igor dolgopolov"'
Publikováno v:
Case Reports in Oncological Medicine, Vol 2017 (2017)
Cumulative myelosuppression is the main limiting factor for administration of repeated cycles of chemotherapy. We present a case series of five pediatric patients with high-risk solid malignancies who received small split peripheral blood stem cells
Externí odkaz:
https://doaj.org/article/91c23196670a46acbb3616db07559d5e
Autor:
Igor Dolgopolov, Maxim Rykov
Publikováno v:
Epidemiology and Infectious Diseases. 26:155-165
BACKGROUND: Monkeypox, a zoonotic disease caused by an orthopoxvirus, results in a smallpox-like or a chickenpox-like disease. Monkeypox in human was first diagnosed in 1970 in the Democratic Republic of the Congo and subsequently has spread to other
Autor:
Igor Dolgopolov, Maxim Rykov
Publikováno v:
Russian Pediatric Journal. :32-39
Introduction. In late 2019, a new subtype of coronavirus named severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) rapidly spread around the world, causing a global pandemic. Initially, the proportion of confirmed cases among childre
Autor:
Igor Dolgopolov, Maxim Rykov
Publikováno v:
Immunologiya. 43:137-148
Publikováno v:
Leukemia-From Biology to Clinic ISBN: 9781803569055
Leukemia-From Biology to Clinic
Leukemia-From Biology to Clinic
The indications for hematopoietic stem cell transplantation (HSCT) in pediatric leukemias continually change with the risk-stratification-based treatment improvement. Achieving the minimal residual disease (MRD) negativity before transplantation, usi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a2804a18aa83ab0ae10dd14ef5a9124
https://doi.org/10.5772/intechopen.107830
https://doi.org/10.5772/intechopen.107830
The incidence of high-grade malignant gliomas (MG) ranges from 35 to 46% of all central nervous system tumors. Despite combined therapy including surgery, radiation and chemotherapy overall five-year survival does not exceed 10%. Our study included 9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::158c7dd88f5bb2bef730d789fd3830f8
https://doi.org/10.22541/au.164487467.70895955/v1
https://doi.org/10.22541/au.164487467.70895955/v1
Autor:
Sergey Gorelyshev, Andrey Levashov, Dmitry Khochenkov, Vadmante Daylidite, Dmitry Sidelnikov, Svetlana Zagidullina, Georgy Seregin, Marina Ryzhova, Anna Stroganova, Igor Dolgopolov, Georgy Mentkevich, Stepan Babelyan, Natalya Subbotina
From 2008 to 2018 forty nine patients with de novo metastatic medulloblastoma were included in trials. Median age is 7.8 years (range, 4 – 17). Children underwent adjuvant therapy arm A (like-SJMB03, n = 14) from 2008 to 2014: craniospinal radiatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a951ec565afb5e5b8f30051233ff376
https://europepmc.org/articles/PMC6477322/
https://europepmc.org/articles/PMC6477322/
Autor:
Sergey Gorelyshev, Anna Stroganova, Svetlana Zagidullina, Igor Dolgopolov, Georgy Seregin, Georgy Mentkevich, Andrey Levashov, Marina Ryzhova, Natalya Subbotina, Stepan Babelyan, Vidmante Daylidite, Dmitry Khochenkov
Publikováno v:
Neuro-Oncology. 20:i120-i121
The aim of this study was to estimate MGMT protein expression and MGMT gene promoter methylation in medulloblastoma specimens and their prognostic significance. Fifty four patients were treated according to like-SJMB03, MTX-OPEC-based, thiophosphamid
Autor:
Ludmila Andreeva, Demur Mscheidze, George Mentkevich, Stuart E. Siegel, Maxim Yankelevich, Igor Dolgopolov
Publikováno v:
American Journal of Hematology. 73:225-229
We retrospectively compared the effects of two time points of G-CSF (Filgrastim) introduction for PBSC mobilization in 45 children with different malignancies. Seventeen patients received the first G-CSF dose on day 2 or 3 following chemotherapy (gro
Autor:
Michail Budarin, George Mentkevich, Vidmante Daylidite, Andrey Levashov, George Chkadua, Igor Dolgopolov
Publikováno v:
Neuro-Oncology. 18:iii50.2-iii50